Rosalind Advisors’s Neuraxis NRXS Stock Holding History

Rosalind Advisors’s Portfolio NRXS Stock Details NRXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.69M	Hold	286,138	–	–	0.68%	27
2025 Q4	$1.04M	Buy	+286,138	New	+$855K	0.37%	31

Other funds holding NRXS

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

MCC

Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return

Panoramic Capital Larkspur, California $142M AUM 161.26% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return

Rosalind Advisors's NRXS Position: Q1 2026 in Review

Rosalind Advisors held its Neuraxis (NRXS) position steady in Q1 2026 at 286,138 shares worth $1.69M. The position accounts for 0.68% of the portfolio, ranked #27.

Rosalind Advisors first reported a position in NRXS in Q4 2025 and has held it in 2 quarters since. 26 funds tracked by Wall St. Rank hold NRXS as of Q1 2026.

Rosalind Advisors held 286,138 shares of Neuraxis worth $1.69M as of Q1 2026.
Rosalind Advisors left its Neuraxis share count unchanged in Q1 2026.
Neuraxis made up 0.68% of Rosalind Advisors's portfolio in Q1 2026, its #27 holding.
Rosalind Advisors first reported a position in Neuraxis in Q4 2025 and has held it in 2 quarters since.
26 funds tracked by Wall St. Rank held Neuraxis as of Q1 2026.

Based on Rosalind Advisors's 13F filing for Q1 2026, filed 14 May 2026.